Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1992 Dec;66(6):1083–1087. doi: 10.1038/bjc.1992.414

Oestrogen receptor isoforms, their distribution and relation to progesterone receptor levels in breast cancer samples.

V A Baker 1, J R Puddefoot 1, S Marsigliante 1, S Barker 1, A W Goode 1, G P Vinson 1
PMCID: PMC1978007  PMID: 1457348

Abstract

Oestrogen receptors (ER) in breast cancer tumours are highly heterogeneous. In this study, the variability in the profile of ER isoforms and its relation to progesterone receptor (PgR) levels in breast tumours has been studied. Using high resolution isoelectric focusing (IEF) 4 ER isoforms can be detected with pI values of 6.1 (corresponding to the 8S ER), and 6.3, 6.6 and 6.8 (all of which have a sedimentation pI values of 6.1 (corresponding to the 8S ER), and 6.3, 6.6 and 6.8 (all of which have a sedimentation coefficient of approximately 4S in sucrose density gradients). Data were obtained on the soluble receptors from supernatants of 66 ER-positive primary breast tumour homogenates using high resolution IEF. In 43 of these samples PgR levels were also measured. The isoform at pI 6.6 was present in 97.0% of tumours, the isoform at pI 6.1 in 83.3%, the pI 6.3 isoform 39.4% of tumours and the pI 6.8 isoform in only 33.3% of tumours. Only 12.1% of tumours studied contained the full complement of ER isoforms (pI 6.1, 6.3, 6.6 & 6.8). The ER isoforms at pI 6.1 & 6.8 were only found in PgR-positive (> 10 fmol PgR/mg protein) tumours. Some tumours contained only a single ER isoform at pI 6.6 or 6.1, but those at pI 6.3 and 6.8 were never found singly. Tumours containing 3 or 4 ER isoforms had significantly higher levels of PgR (> 90 fmol/mg protein) than those with only 1 or 2 (P < 0.001). The presence of ER isoforms at pI 6.3 and pI 6.8 also significantly correlated with high levels of PgR (P < 0.001). This variability in the ER isoform profile of breast tumours and their correlation with PgR levels may have a bearing on prognosis and tumour response to endocrine therapy.

Full text

PDF
1083

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander I. E., Clarke C. L., Shine J., Sutherland R. L. Progestin inhibition of progesterone receptor gene expression in human breast cancer cells. Mol Endocrinol. 1989 Sep;3(9):1377–1386. doi: 10.1210/mend-3-9-1377. [DOI] [PubMed] [Google Scholar]
  2. Bailleul S., Gauduchon P., Malas J. P., Lechevrel C., Roussel G., Goussard J. Charge heterogeneity of human mammary tumor estrogen receptors. Relationship with a hormonal sensitivity tumor marker. Cancer Lett. 1988 Jun 30;40(3):299–307. doi: 10.1016/0304-3835(88)90089-4. [DOI] [PubMed] [Google Scholar]
  3. Bailleul S., Gauduchon P., Malas J. P., Lechevrel C., Roussel G., Goussard J. Steroid receptors analysis in human mammary tumors by isoelectric focusing in agarose. Anal Biochem. 1988 Aug 1;172(2):311–319. doi: 10.1016/0003-2697(88)90450-2. [DOI] [PubMed] [Google Scholar]
  4. Fuqua S. A., Fitzgerald S. D., Chamness G. C., Tandon A. K., McDonnell D. P., Nawaz Z., O'Malley B. W., McGuire W. L. Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res. 1991 Jan 1;51(1):105–109. [PubMed] [Google Scholar]
  5. Garcia T., Lehrer S., Bloomer W. D., Schachter B. A variant estrogen receptor messenger ribonucleic acid is associated with reduced levels of estrogen binding in human mammary tumors. Mol Endocrinol. 1988 Sep;2(9):785–791. doi: 10.1210/mend-2-9-785. [DOI] [PubMed] [Google Scholar]
  6. Garcia T., Sanchez M., Cox J. L., Shaw P. A., Ross J. B., Lehrer S., Schachter B. Identification of a variant form of the human estrogen receptor with an amino acid replacement. Nucleic Acids Res. 1989 Oct 25;17(20):8364–8364. doi: 10.1093/nar/17.20.8364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Green S., Walter P., Kumar V., Krust A., Bornert J. M., Argos P., Chambon P. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature. 1986 Mar 13;320(6058):134–139. doi: 10.1038/320134a0. [DOI] [PubMed] [Google Scholar]
  8. Horwitz K. B., McGuire W. L. Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. J Biol Chem. 1978 Apr 10;253(7):2223–2228. [PubMed] [Google Scholar]
  9. Hutchens T. W., Hawkins E. F., Markland F. S., Jr Identification of transformed glucocorticoid receptor from dexamethasone resistant melanoma. J Steroid Biochem. 1982 Jun;16(6):705–711. doi: 10.1016/0022-4731(82)90023-1. [DOI] [PubMed] [Google Scholar]
  10. Hutchens T. W., Wiehle R. D., Shahabi N. A., Wittliff J. L. Rapid analysis of estrogen receptor heterogeneity by chromatofocusing with high-performance liquid chromatography. J Chromatogr. 1983 Aug 26;266:115–128. doi: 10.1016/s0021-9673(01)90884-2. [DOI] [PubMed] [Google Scholar]
  11. Isomaa V., Isotalo H., Orava M., Jänne O. Regulation of cytosol and nuclear progesterone receptors in rabbit uterus by estrogen, antiestrogen and progesterone administration. Biochim Biophys Acta. 1979 Jun 1;585(1):24–33. doi: 10.1016/0304-4165(79)90321-0. [DOI] [PubMed] [Google Scholar]
  12. Jensen E. V., Hurst D. J., DeSombre E. R., Jungblut P. W. Sulfhydryl groups and estradiol-receptor interaction. Science. 1967 Oct 20;158(3799):385–387. doi: 10.1126/science.158.3799.385. [DOI] [PubMed] [Google Scholar]
  13. Jensen E. V., Numata M., Brecher P. I., Desombre E. R. Hormone-receptor interaction as a guide to biochemical mechanism. Biochem Soc Symp. 1971;32:133–159. [PubMed] [Google Scholar]
  14. Kute T. E., Heidemann P., Wittliff J. L. Molecular heterogeneity of cytosolic forms of estrogen receptors from human breast tumors. Cancer Res. 1978 Nov;38(11 Pt 2):4307–4313. [PubMed] [Google Scholar]
  15. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  16. Marsigliante S., Baker V. A., Puddefoot J., Barker S., Vinson G. P. 4 S oestrogen receptor isoforms and their distribution in breast cancer samples. J Mol Endocrinol. 1991 Dec;7(3):205–211. doi: 10.1677/jme.0.0070205. [DOI] [PubMed] [Google Scholar]
  17. Marsigliante S., Puddefoot J. R., Barker S., Gledhill J., Vinson G. P. Discrepancies between antibody (EIA) and saturation analysis of oestrogen receptor content in breast tumour samples. J Steroid Biochem Mol Biol. 1990 Dec 10;37(5):643–648. doi: 10.1016/0960-0760(90)90346-m. [DOI] [PubMed] [Google Scholar]
  18. Marsigliante S., Puddefoot J. R., Barker S., Goode A. W., Vinson G. P. Significance of the 8S complex in oestrogen receptor recognition. J Steroid Biochem Mol Biol. 1991 Nov;39(5A):703–711. doi: 10.1016/0960-0760(91)90370-k. [DOI] [PubMed] [Google Scholar]
  19. May F. E., Johnson M. D., Wiseman L. R., Wakeling A. E., Kastner P., Westley B. R. Regulation of progesterone receptor mRNA by oestradiol and antioestrogens in breast cancer cell lines. J Steroid Biochem. 1989 Dec;33(6):1035–1041. doi: 10.1016/0022-4731(89)90406-8. [DOI] [PubMed] [Google Scholar]
  20. McGuire W. L., Clark G. M. Role of progesterone receptors in breast cancer. Semin Oncol. 1985 Mar;12(1 Suppl 1):12–16. [PubMed] [Google Scholar]
  21. McGuire W. L., De La Garza M., Chamness G. C. Evaluation of estrogen receptor assays in human breast cancer tissue. Cancer Res. 1977 Mar;37(3):637–639. [PubMed] [Google Scholar]
  22. Mester J., Baulieu E. E. Progesterone receptors in the chick oviduct. Determination of the total concentration of binding sites in the cytosol and nuclear fraction and effect of progesterone on their distribution. Eur J Biochem. 1977 Jan;72(2):405–414. doi: 10.1111/j.1432-1033.1977.tb11265.x. [DOI] [PubMed] [Google Scholar]
  23. Milgrom E., Thi L., Atger M., Baulieu E. E. Mechanisms regulating the concentration and the conformation of progesterone receptor(s) in the uterus. J Biol Chem. 1973 Sep 25;248(18):6366–6374. [PubMed] [Google Scholar]
  24. Murphy L. C., Dotzlaw H. Variant estrogen receptor mRNA species detected in human breast cancer biopsy samples. Mol Endocrinol. 1989 Apr;3(4):687–693. doi: 10.1210/mend-3-4-687. [DOI] [PubMed] [Google Scholar]
  25. Murphy L. C. Estrogen receptor variants in human breast cancer. Mol Cell Endocrinol. 1990 Dec 3;74(2):C83–C86. doi: 10.1016/0303-7207(90)90109-l. [DOI] [PubMed] [Google Scholar]
  26. Müller R. E., Traish A. M., Wotiz H. H. Estrogen receptor activation precedes transformation. Effects of ionic strength, temperature, and molybdate. J Biol Chem. 1983 Aug 10;258(15):9227–9236. [PubMed] [Google Scholar]
  27. Puca G. A., Nola E., Sica V., Bresciani F. Estrogen-binding proteins of calf uterus. Partial purification and preliminary characterization of two cytoplasmic proteins. Biochemistry. 1971 Sep 28;10(20):3769–3780. doi: 10.1021/bi00796a020. [DOI] [PubMed] [Google Scholar]
  28. Read L. D., Snider C. E., Miller J. S., Greene G. L., Katzenellenbogen B. S. Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines. Mol Endocrinol. 1988 Mar;2(3):263–271. doi: 10.1210/mend-2-3-263. [DOI] [PubMed] [Google Scholar]
  29. Sica V., Nola E., Puca G. A., Bresciani F. Estrogen binding proteins of calf uterus. Inhibition of aggregation and dissociation of receptor by chemical perturbation with NaSCN. Biochemistry. 1976 May 4;15(9):1915–1923. doi: 10.1021/bi00654a019. [DOI] [PubMed] [Google Scholar]
  30. Vu Hai M. T., Warembourg M., Milgrom E. Hormonal control of progesterone receptors. Ann N Y Acad Sci. 1977 Mar 11;286:199–209. doi: 10.1111/j.1749-6632.1977.tb29417.x. [DOI] [PubMed] [Google Scholar]
  31. Wiehle R. D., Hofmann G. E., Fuchs A., Wittliff J. L. High-performance size exclusion chromatography as a rapid method for the separation of steroid hormone receptors. J Chromatogr. 1984 Apr 13;307(1):39–51. doi: 10.1016/s0378-4347(00)84071-2. [DOI] [PubMed] [Google Scholar]
  32. Wittliff J. L., Hilf R., Brooks W. F., Jr, Savlov E. D., Hall T. C., Orlando R. A. Specific estrogen-binding capacity of the cytoplasmic receptor in normal and neoplastic breast tissues of humans. Cancer Res. 1972 Sep;32(9):1983–1992. [PubMed] [Google Scholar]
  33. Wittliff J. L. Steroid-hormone receptors in breast cancer. Cancer. 1984 Feb 1;53(3 Suppl):630–643. doi: 10.1002/1097-0142(19840201)53:3+<630::aid-cncr2820531308>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  34. Wrange O., Nordenskjöld B., Gustafsson J. A. Cytosol estradiol receptor in human mammary carcinoma: an assay based on isoelectric focusing in polyacrylamide gel. Anal Biochem. 1978 Apr;85(2):461–475. doi: 10.1016/0003-2697(78)90243-9. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES